Disposing of Recalled, Rejected and Expired Pharmaceuticals:EPA, DEA and State Regulations Create Havoc
Staying out of trouble takes more than compliance with the Resource Conservation and Recovery Act (RCRA). You’ve got to mesh all the relevant EPA rules with DEA requirements as well as widely differing — and often tougher — state regulations.
How can you make sure you cover all the bases? And what about new bases to cover — like the possible impact of the EPA’s Universal Waste Rule and “product stewardship” proposals?
This is no time to risk confusion over the jumble of state and federal rules that govern how you handle, transport and dispose of pharmaceuticals.
Avoid today’s top five disposal pitfalls
Pharmaceutical waste expert Charlotte Smith will show you today’s top five pitfalls and help you translate RCRA requirements into a practical, fully compliant program for discarding recalled, rejected and expired products. You’ll come away with a detailed roadmap for determining which EPA, DEA and state regulations apply to your drugs and biologics. Plus, you’ll know what to expect — and what to do now — to prepare for the possible impact of changes and new rules.
Order now for your entire team to get clear guidance and best practices on how to deal with drug waste disposal, including:
- What drugs are on RCRA’s hazardous waste lists — including the latest changes made this year by the EPA
- How to tell if nonlisted pharmaceuticals meet other EPA hazardous waste criteria
- What to do now to avoid those five common — yet costly — pitfalls
- How to meet DEA requirements every step of the way: handling, waste transfer, disposal and the “witnessed burn” process
- Critical transport issues that apply — even if pharmaceuticals aren’t classified as hazardous
- How to sort out state regulations and steer clear of problems\
- Best management practices for disposing of nonhazardous drugs
- Steps to take now to address Universal Waste Rule inclusion of drugs
- What “product stewardship” could mean for the industry — and your bottom line